AIMEDBIO
PR
ENG
KOR
ABOUT US
Overview
Leadership
Corporate Governance
R&D
AimedBio’s Drug Development
P-ADC™
Pipeline
IR
Disclosure
Stock
Financial Information
PR
Notice
Press Release
Data Room
CAREERS
Our Culture
Recruitment Process
Job Opportunities
Press Release
36 posts
Title
Content
Search
17
2025.04
AimedBio Receives MFDS IND Approval for AMB302
VIEW MORE
14
2025.02
AMB302 Designated as FDA Orphan Drug for Head and Neck Cancer
VIEW MORE
14
2025.01
AimedBio Licensed-out FGFR3-Targeting ADC AMB302 to Biohaven
VIEW MORE
10
2024.12
AMB302 Selected as Outstanding Project in KDDF Program
VIEW MORE
22
2024.11
2nd Samsung Medical Center × AimedBio ADC Conference Held with Over 500 Participants
VIEW MORE
1
2
3
4
5
